// App-Quantinova.ai

612 : Thromboembolic Events Are Not Associated with Anti-Adalimumab Antibodies

Researchers

Presenter

  • Gerd Burmester

Principal Investigators

  • Cem Gabay

  • Dilek Arikan

  • Anabela Cardoso

  • Jasmina Kalabic

  • Nathan Pfeifer

  • Nupun A. Varothai

  • Stefan Florentinus

  • Josef S. Smolen

Medical Centers

  • Department of OB/GYN, Division of Senology, Medical University of Vienna, Vienna, Austria

  • Centre of Oncology, Geneva University Hospital, Geneva, Switzerland

  • Department of Rheumatology and Clinical Immunology, Charite - Universitatsmedizin Berlin, Berlin, Germany

Locations

  • Germany

  • Switzerland

  • Austria

Companies

  • AbbVie Inc.

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Superficial Vein Thrombosis

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Myocardial infarction

  • Deep vein thrombosis

  • Pulmonary embolism

  • Venous thrombosis

Biomarkers

  • Amyloid Precursor Protein

Drug/Treatment

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved